When the FDA found “sterility failures” after its inspection of compounding pharmacy Downing Lab, the agency asked the company to recall certain products. But the company’s co-owner, Ashley Downing, refused. Jim Axelrod interviewed Downing to find out why.
This post was originally published on this site